KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Times Interest Earned (2017 - 2025)

Regeneron Pharmaceuticals has reported Times Interest Earned over the past 16 years, most recently at $72.12 for Q4 2025.

  • Quarterly results put Times Interest Earned at $72.12 for Q4 2025, down 23.52% from a year ago — trailing twelve months through Dec 2025 was $81.69 (up 12.99% YoY), and the annual figure for FY2025 was $81.69, up 12.99%.
  • Times Interest Earned for Q4 2025 was $72.12 at Regeneron Pharmaceuticals, up from $53.2 in the prior quarter.
  • Over the last five years, Times Interest Earned for REGN hit a ceiling of $299.86 in Q2 2025 and a floor of $46.67 in Q1 2024.
  • Median Times Interest Earned over the past 5 years was $74.24 (2024), compared with a mean of $98.15.
  • Biggest five-year swings in Times Interest Earned: crashed 64.8% in 2022 and later surged 314.92% in 2025.
  • Regeneron Pharmaceuticals' Times Interest Earned stood at $187.21 in 2021, then crashed by 64.8% to $65.91 in 2022, then dropped by 19.34% to $53.16 in 2023, then soared by 77.38% to $94.3 in 2024, then dropped by 23.52% to $72.12 in 2025.
  • The last three reported values for Times Interest Earned were $72.12 (Q4 2025), $53.2 (Q3 2025), and $299.86 (Q2 2025) per Business Quant data.